http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111643498-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 |
| filingDate | 2020-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111643498-B |
| titleOfInvention | Pharmaceutical composition for treating kidney stone and application thereof |
| abstract | The invention discloses a pharmaceutical composition for treating kidney stone and application thereof. Particularly, the pharmaceutical composition for treating kidney stones provided by the invention is a solid dispersion prepared by using 5-methyl-4- [ ({ (1R,2R) -2- [4- (3-methyl-1H-pyrazol-5-yl) benzoyl ] -cyclohexyl } carbonyl) amino ] -1H-pyrazole-3-formamide as an active ingredient. The invention also relates to the use of said compounds for producing medicaments for treating kidney stones. |
| priorityDate | 2020-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.